Literature DB >> 15857744

Validation of a modified version of the brief pain inventory for painful diabetic peripheral neuropathy.

Diane C Zelman1, Mugdha Gore, Ellen Dukes, Kei-Sing Tai, Nancy Brandenburg.   

Abstract

Neuropathic pain is the focus of current clinical research, clinical identification, and treatment. It is unique from nociceptive pain and requires evaluation of the relevance and utility of common pain measures created for other painful conditions. This study evaluated the psychometric properties of a modified Brief Pain Inventory (BPI) for patients with painful diabetic peripheral neuropathy (BPI-DPN). Participants were patients with painful DPN (n=255) enrolled in a DPN Burden of Illness survey referred through 17 outpatient settings (primary care physicians, endocrinologists, neurologists, and anesthesiologists). Patients completed the BPI-DPN, and self-report measures of health-related quality of life, mood sleep, and healthcare utilization. Construct, criterion and discriminant validity, and internal consistency reliability were evaluated. Principal axis factoring with oblimin rotation revealed two interpretable factors (eigenvalues>1.0), consistent with most published BPI validation studies; a severity scale comprising the four BPI Severity items and an interference scale comprising the seven Interference items, which satisfied criteria for interpretability and model fit. Cronbach's alpha was high (0.94) for both scales. Mean pain Severity was highly correlated with Bodily Pain from the Medical Outcomes Study Short Form-12, version 2 (rs=0.63, P < 0.001), the Pain/Discomfort item in the Euro-QoL (rs=0.58, P < 0.001), and a verbal rating scale measure of pain severity (rs=0.74, P < 0.001). Individual BPI-DPN Interference domains were moderately correlated (rs's >0.5, P < 0.001) with analogous measures, and the Sleep Interference item had a high, significant association with the three primary Medical Outcome Study-Sleep scale subscales (rs's=0.66-71, P < 0.001). Worst Pain and Interference ratings were significantly associated with hospital utilization and outpatient visits due to DPN. These results replicate, in a pure peripheral neuropathic pain condition, the BPI psychometric characteristics documented in populations with nociceptive or mixed pain conditions. The BPI-DPN is a promising instrument in the evaluation of painful DPN.

Entities:  

Mesh:

Year:  2005        PMID: 15857744     DOI: 10.1016/j.jpainsymman.2004.06.018

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  44 in total

1.  Intersectional health-related stigma in persons living with HIV and chronic pain: implications for depressive symptoms.

Authors:  Burel R Goodin; Michael A Owens; Dyan M White; Larissa J Strath; Cesar Gonzalez; Rachael L Rainey; Jennifer I Okunbor; Sonya L Heath; Janet M Turan; Jessica S Merlin
Journal:  AIDS Care       Date:  2018-05-30

2.  Activity for Diabetic Polyneuropathy (ADAPT): Study Design and Protocol for a 2-Site Randomized Controlled Trial.

Authors:  Patricia M Kluding; J Robinson Singleton; Mamatha Pasnoor; Mazen M Dimachkie; Richard J Barohn; A Gordon Smith; Robin L Marcus
Journal:  Phys Ther       Date:  2017-01-01

Review 3.  Psychometric validation of the SF-36® Health Survey in ulcerative colitis: results from a systematic literature review.

Authors:  Aaron Yarlas; Martha Bayliss; Joseph C Cappelleri; Stephen Maher; Andrew G Bushmakin; Lea Ann Chen; Alireza Manuchehri; Paul Healey
Journal:  Qual Life Res       Date:  2017-08-28       Impact factor: 4.147

Review 4.  Pharmacological treatment of diabetic neuropathic pain.

Authors:  Howard S Smith; Charles E Argoff
Journal:  Drugs       Date:  2011-03-26       Impact factor: 9.546

5.  A pragmatic observational feasibility study on integrated treatment for musculoskeletal disorders: Design and protocol.

Authors:  Xiao-yang Hu; John Hughes; Peter Fisher; Ava Lorenc; Rachel Purtell; A-La Park; Nicola Robinson
Journal:  Chin J Integr Med       Date:  2013-12-13       Impact factor: 1.978

6.  Enhanced facilitation and diminished inhibition characterizes the pronociceptive endogenous pain modulatory balance of persons living with HIV and chronic pain.

Authors:  Michael A Owens; Romy Parker; Rachael L Rainey; Cesar E Gonzalez; Dyan M White; Anooshah E Ata; Jennifer I Okunbor; Sonya L Heath; Jessica S Merlin; Burel R Goodin
Journal:  J Neurovirol       Date:  2018-11-09       Impact factor: 2.643

7.  The impact of enrollment in a specialized interdisciplinary neuropathic pain clinic.

Authors:  Alexandra Garven; Shauna Brady; Susan Wood; Melinda Hatfield; Jennifer Bestard; Lawrence Korngut; Cory Toth
Journal:  Pain Res Manag       Date:  2011 May-Jun       Impact factor: 3.037

8.  Toward characterization and definition of fibromyalgia severity.

Authors:  Stuart Silverman; Alesia Sadosky; Chris Evans; Yating Yeh; Jose Ma J Alvir; Gergana Zlateva
Journal:  BMC Musculoskelet Disord       Date:  2010-04-08       Impact factor: 2.362

Review 9.  Impact of Diabetic Complications on Balance and Falls: Contribution of the Vestibular System.

Authors:  Linda J D'Silva; James Lin; Hinrich Staecker; Susan L Whitney; Patricia M Kluding
Journal:  Phys Ther       Date:  2015-08-06

10.  Randomized placebo-controlled double-blind clinical trial of cannabis-based medicinal product (Sativex) in painful diabetic neuropathy: depression is a major confounding factor.

Authors:  Dinesh Selvarajah; Rajiv Gandhi; Celia J Emery; Solomon Tesfaye
Journal:  Diabetes Care       Date:  2009-10-06       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.